Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;8(7):e1231.
doi: 10.1002/mgg3.1231. Epub 2020 Apr 29.

Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province

Affiliations

Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province

Yujing Cheng et al. Mol Genet Genomic Med. 2020 Jul.

Abstract

Background: Pharmacogenomics plays a crucial role in individualized therapy, but the variant information of pharmacogenomics in the Dai population is limited. We therefore aimed to screen very important pharmacogenetic (VIP) in the Dai population and compared differences between Dai and other 25 populations.

Methods: In this study, we genotyped 73 VIP variants from the PharmGKB and compared genotype distribution of variants in Dai with other 25 populations by χ2 test. To assess the genetic relationship among 26 populations, we performed the structure analysis. In addition, pair-wise F-statistics (Fst) was calculated to measure the population differentiation.

Results: We found 12, 10, 13, 17, 11, 39, 46, 46, 45, 43, 49, 46, 46, 46, 49, 45, 41, 42, 48, 53, 45, 50, 50, 51, 47, and 50 significantly different variants in Dai compared with other 25 populations. Genetic structure analysis showed Dai had close relationships with CDX (Chinese Dai in Xishuangbanna), CHB (Han Chinese in Beijing), JPT (Japanese in Tokyo), and KHV (Kinh in Ho Chi Minh City, Vietnam). Moreover, Dai is the most similar to KHV according to Fst analysis.

Conclusions: Our study complement the pharmacogenomics information of Dai population from Yunnan province and provide a theoretical basis for personalized medicine.

Keywords: Dai; genetic polymorphisms; populations; very important pharmacogenetic.

PubMed Disclaimer

Conflict of interest statement

We declare no conflict of interest in this study.

Figures

Figure 1
Figure 1
The allele frequencies of PTGS2 rs20417, TPMT rs1142345, and CYP2A6 rs28399433 in 26 populations. 1: Dai, 2: CDX, 3: CHB, 4: JPT, 5: KHV, 6: BEB, 7: GIH, 8: ITU, 9: PJL, 10: STU, 11: CEU, 12: FIN, 13: GBR, 14: IBS, 15: TSI, 16: CLM, 17: MXL, 18: PEL, 19: PUR, 20: ACB, 21: ASW, 22: ESN, 23: GWD, 24: LWK, 25: MSL, 26: YRI
Figure 2
Figure 2
Structure analysis of the genetic relationship of Dai and the other 25 populations

References

    1. Ariyoshi, N. , Miyamoto, M. , Umetsu, Y. , Kunitoh, H. , Dosaka‐Akita, H. , Sawamura, Y.‐I. , … Kamataki, T. (2002). Genetic polymorphism of CYP2A6 gene and tobacco‐induced lung cancer risk in male smokers. Cancer Epidemiology and Prevention Biomarkers, 11, 890–894. - PubMed
    1. Corpman, D. W.. (2013). Mobile health in China: A review of research and programs in medical care, health education, and public health. Journal of Health Communication, 18, 1345–1367. - PubMed
    1. Daraei, A. , Salehi, R. , & Mohamadhashem, F. (2012). PTGS2 (COX2)− 765G> C gene polymorphism and risk of sporadic colorectal cancer in Iranian population. Molecular Biology Reports, 39, 5219–5224. - PubMed
    1. Ding, Y. , He, P. , He, N. , Li, Q. , Sun, J. , Yao, J. , … Wang, X. (2016). Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China. Environmental Toxicology and Pharmacology, 42, 237–242. - PubMed
    1. Evans, W. E. , & Relling, M. V. (1999). Pharmacogenomics: Translating functional genomics into rational therapeutics. Science, 286, 487–491. - PubMed